Genece Health
Genece Health is a company focused on advancing cancer detection through a single blood draw using liquid biopsy combined with AI and a multi-algorithmic approach. They leverage low-pass whole genome sequencing (LP-WGS) and proprietary machine learning, including deep learning trained on thousands of samples, to analyze genetic features and detect circulating tumor DNA. Their high-complexity, CLIA-certified/CAP-accredited lab targets areas of acute need, particularly in women's health and high-mortality cancers. Genece Health has a strategic partnership with GC Genome and GC Corporation from South Korea, a major life sciences company, to bring disruptive technology to the U.S. and accelerate the delivery of their cancer care solutions.
Genece Health
Genece Health is a company focused on advancing cancer detection through a single blood draw using liquid biopsy combined with AI and a multi-algorithmic approach. They leverage low-pass whole genome sequencing (LP-WGS) and proprietary machine learning, including deep learning trained on thousands of samples, to analyze genetic features and detect circulating tumor DNA. Their high-complexity, CLIA-certified/CAP-accredited lab targets areas of acute need, particularly in women's health and high-mortality cancers. Genece Health has a strategic partnership with GC Genome and GC Corporation from South Korea, a major life sciences company, to bring disruptive technology to the U.S. and accelerate the delivery of their cancer care solutions.